| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |